SEASONAL INFLUENZA IN THE MIDST OF COVID-19 The World Health Organization(WHO)named the disease caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)as coronavirus disease 2019(COVID-19)and declared th...SEASONAL INFLUENZA IN THE MIDST OF COVID-19 The World Health Organization(WHO)named the disease caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)as coronavirus disease 2019(COVID-19)and declared the outbreak a Public Health Emergency of International Concern(PHEIC)on January 30,2020 and a pandemic on March 11,2020.Globally,there have been 239,437,517 confirmed cases of COVID-19 reported to WHO,including 4,879,235(2.1%)deaths as of October 15,2021(1).The COVID-19 pandemic continues to cause an unparalleled impact on global public health security and economic well-being in the context of previous influenza pandemics as well as other emerging infectious diseases in history(2).As the epidemiology,clinical presentations,and control measures for SARS-CoV-2 and influenza share many features,there is a need to develop strategies to address additional challenges arising in the continued surveillance,prevention,and clinical management of influenza in conjunction with COVID-19 pandemic responses.展开更多
文摘SEASONAL INFLUENZA IN THE MIDST OF COVID-19 The World Health Organization(WHO)named the disease caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)as coronavirus disease 2019(COVID-19)and declared the outbreak a Public Health Emergency of International Concern(PHEIC)on January 30,2020 and a pandemic on March 11,2020.Globally,there have been 239,437,517 confirmed cases of COVID-19 reported to WHO,including 4,879,235(2.1%)deaths as of October 15,2021(1).The COVID-19 pandemic continues to cause an unparalleled impact on global public health security and economic well-being in the context of previous influenza pandemics as well as other emerging infectious diseases in history(2).As the epidemiology,clinical presentations,and control measures for SARS-CoV-2 and influenza share many features,there is a need to develop strategies to address additional challenges arising in the continued surveillance,prevention,and clinical management of influenza in conjunction with COVID-19 pandemic responses.
